相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets
Rory D. de Vries et al.
SCIENCE (2021)
Marked structural rearrangement of mannose 6-phosphate/IGF2 receptor at different pH environments
Rong Wang et al.
SCIENCE ADVANCES (2020)
How IGF-II Binds to the Human Type 1 Insulin-like Growth Factor Receptor
Yibin Xu et al.
STRUCTURE (2020)
Lysosome-targeting chimaeras for degradation of extracellular proteins
Steven M. Banik et al.
NATURE (2020)
Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain
Victor K. Outlaw et al.
MBIO (2020)
Antibody Delivery for Intracellular Targets: Emergent Therapeutic Potential
Khushboo Singh et al.
BIOCONJUGATE CHEMISTRY (2019)
Therapeutic strategies to target the Ebola virus life cycle
Thomas Hoenen et al.
NATURE REVIEWS MICROBIOLOGY (2019)
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates
Zachary A. Bornholdt et al.
CELL HOST & MICROBE (2019)
Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection
Anna Z. Wec et al.
CELL HOST & MICROBE (2019)
Characterization of a filovirus (Mengla virus) from Rousettus bats in China
Xing-Lou Yang et al.
NATURE MICROBIOLOGY (2019)
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
Pavlo Gilchuk et al.
IMMUNITY (2018)
Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins
Elisabeth K. Nyakatura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates
Kristen E. Pascal et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
The phorbol 12-myristate-13-acetate differentiation protocol is critical to the interaction of THP-1 macrophages with Salmonella Typhimurium
Tregei Starr et al.
PLOS ONE (2018)
Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism
Watee Seesuay et al.
EMERGING MICROBES & INFECTIONS (2018)
Effective in Vivo Targeting of Influenza Virus through a Cell-enetrating/Fusion Inhibitor Tandem Peptide Anchored to the Plasma Membrane
T. N. Figueira et al.
BIOCONJUGATE CHEMISTRY (2018)
The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses
Tracey Goldstein et al.
NATURE MICROBIOLOGY (2018)
Treatment strategies for lysosomal storage disorders
Michael Beck
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)
Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases
Y. Wang et al.
MOLECULAR NEUROBIOLOGY (2017)
Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides
Cyrille Mathieu et al.
SCIENTIFIC REPORTS (2017)
Clearance of Heparan Sulfate and Attenuation of CNS Pathology by Intracerebroventricular BMN 250 in Sanfilippo Type B Mice
Mika Aoyagi-Scharber et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses
Anna Z. Wec et al.
CELL (2017)
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability
Xuelian Zhao et al.
CELL (2017)
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses
Frederick W. Holtsberg et al.
JOURNAL OF VIROLOGY (2016)
Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection
Xin Gong et al.
CELL (2016)
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection
Andrew I. Flyak et al.
CELL (2016)
Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1
Han Wang et al.
CELL (2016)
Clues to the mechanism of cholesterol transfer from the structure of NPC1 middle lumenal domain bound to NPC2
Xiaochun Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A Trojan horse bispecific-antibody strategy for broad protection against ebolaviruses
Anna Z. Wec et al.
SCIENCE (2016)
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Davide Corti et al.
SCIENCE (2016)
Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies
Zachary A. Bornholdt et al.
MBIO (2016)
Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses
Julia C. Frei et al.
SCIENTIFIC REPORTS (2016)
Structural Basis for Marburg Virus Neutralization by a Cross-Reactive Human Antibody
Takao Hashiguchi et al.
CELL (2015)
Mechanism of Human Antibody-Mediated Neutralization of Marburg Virus
Andrew I. Flyak et al.
CELL (2015)
Identification of a fourth mannose 6-phosphate binding site in the cation-independent mannose 6-phosphate receptor
Linda J. Olson et al.
GLYCOBIOLOGY (2015)
Transbody against hepatitis B virus core protein inhibits hepatitis B virus replication in vitro
Yawen Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Ebola and Marburg haemorrhagic fever
V. Rougeron et al.
JOURNAL OF CLINICAL VIROLOGY (2015)
Niemann-Pick C1 Is Essential for Ebolavirus Replication and Pathogenesis In Vivo
Andrew S. Herbert et al.
MBIO (2015)
Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion
Lara M. Kleinfelter et al.
MBIO (2015)
Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection
Feiran Lu et al.
ELIFE (2015)
Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats
Melinda Ng et al.
ELIFE (2015)
Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of α-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts
Shih-hsin Kan et al.
BIOCHEMICAL JOURNAL (2014)
Characterization of the Envelope Glycoprotein of a Novel Filovirus, Lloviu Virus
Junki Maruyama et al.
JOURNAL OF VIROLOGY (2014)
Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB
Shih-hsin Kan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1
Melinda Ng et al.
VIROLOGY (2014)
Glycosylation-independent Lysosomal Targeting of Acid α-Glucosidase Enhances Muscle Glycogen Clearance in Pompe Mice
John A. Maga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Ebola virus entry requires the host-programmed recognition of an intracellular receptor
Emily Happy Miller et al.
EMBO JOURNAL (2012)
A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity
Antonello Pessi et al.
PLOS ONE (2012)
Capturing a Fusion Intermediate of Influenza Hemagglutinin with a Cholesterol-conjugated Peptide, a New Antiviral Strategy for Influenza Virus
Kelly K. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inhibition of Ebola Virus Entry by a C-peptide Targeted to Endosomes
Emily Happy Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection
Marceline Cote et al.
NATURE (2011)
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1
Jan E. Carette et al.
NATURE (2011)
Protein Replacement Therapy Partially Corrects the Cholesterol-Storage Phenotype in a Mouse Model of Niemann-Pick Type C2 Disease
Gitte Krogh Nielsen et al.
PLOS ONE (2011)
Discovery of an Ebolavirus-Like Filovirus in Europe
Ana Negredo et al.
PLOS PATHOGENS (2011)
Therapy for Lysosomal Storage Disorders
Michael Beck
IUBMB LIFE (2010)
A Forward Genetic Strategy Reveals Destabilizing Mutations in the Ebolavirus Glycoprotein That Alter Its Protease Dependence during Cell Entry
Anthony C. Wong et al.
JOURNAL OF VIROLOGY (2010)
New Strategies for Enzyme Replacement Therapy for Lysosomal Storage Diseases
Jeffrey H. Grubb et al.
REJUVENATION RESEARCH (2010)
Cation-independent Mannose 6-Phosphate Receptor A COMPOSITE OF DISTINCT PHOSPHOMANNOSYL BINDING SITES
Richard N. Bohnsack et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Glycoengineered Acid alpha-Glucosidase With Improved Efficacy at Correcting the Metabolic Aberrations and Motor Function Deficits in a Mouse Model of Pompe Disease
Yunxiang Zhu et al.
MOLECULAR THERAPY (2009)
Keeping IGF-II under control: Lessons from the IGF-II-IGF2R crystal structure
James Brown et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Strategies for carbohydrate recognition by the mannose 6-phosphate receptors
Nancy M. Dahms et al.
GLYCOBIOLOGY (2008)
Ebola virus glycoprotein 1: Identification of residues important for binding and postbinding events
Melinda A. Brindley et al.
JOURNAL OF VIROLOGY (2007)
Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein
K Schornberg et al.
JOURNAL OF VIROLOGY (2006)
Mannose 6-phosphate receptors, Niemann-Pick C2 protein, and lysosomal cholesterol accumulation
M Willenborg et al.
JOURNAL OF LIPID RESEARCH (2005)
Carbohydrate-remodel led acid α-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice
YX Zhu et al.
BIOCHEMICAL JOURNAL (2005)
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection
K Chandran et al.
SCIENCE (2005)
Comprehensive analysis of Ebola virus GP1 in viral entry
B Manicassamy et al.
JOURNAL OF VIROLOGY (2005)
Glycosylation-independent taraetina enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice
JH LeBowitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Transduction peptides: from technology to physiology
A Joliot et al.
NATURE CELL BIOLOGY (2004)
Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis - Correlation of binding affinity with ability to prevent apoptosis
BE Forbes et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Real time kinetics of insulin-like growth factor II (IGF-II) interaction with the IGF-II/mannose 6-phosphate receptor - The effects of domain 13 and pH
J Linnell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Identification of HE1 as the second gene of Niemann-Pick C disease
S Naureckiene et al.
SCIENCE (2000)
分享论文
